Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation.

J Clin Med · 2023 · PMC10607242 · PMID 37892824

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

of borderline significancep = 0.06so close (0.05 < p ≤ 0.1)

full-dose rivaroxaban was associated with a lower risk of clinically relevant bleeding complications (aHR: 0.62, 95% CI: 0.39–0.97, p = 0.03) and was associated with gastrointestinal bleeding at a level of borderline significance (aHR: 0.52, 95% CI: 0.26–1.03, p = 0.06).

also in 389 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.